![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H22N4O5 |
Molar mass | 386.408 g·mol−1 |
3D model (JSmol) | |
| |
|
MK6892 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 2 (GPR109A). It has been investigated for lowering blood lipid levels and potential applications in the treatment of colon cancer. [1] [2] [3] [4]